Cigna Group
CINYSECIK 1739940FinancialsFiscal year ends Dec 31
Reports and events: 175 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0920:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-26-039271 |
| 2026-09-3011:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-038056 |
| 2026-07-3016:37 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001739940-26-000065 |
| 2026-07-3010:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-030135 |
| 2026-05-1310:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-26-020906 |
| 2026-04-3015:47 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001739940-26-000043 |
| 2026-04-3010:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-017971 |
| 2026-04-2720:26 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-017123 |
| 2026-03-1320:36 ET | DEF 14A | Proxy statementPeriod 2026-04-22 | 0001739940-26-000023 |
| 2026-03-0312:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-007450 |
| 2026-02-2711:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-26-007049 |
| 2026-02-2617:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001739940-26-000006 |
| 2026-02-0511:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-003768 |
| 2025-11-1821:15 ET | 8-K | 8.01 Other events | 0001140361-25-042597 |
| 2025-10-3016:20 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001739940-25-000037 |
| 2025-10-3010:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-039777 |
| 2025-10-2020:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-038670 |
| 2025-09-0420:08 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033986 |
| 2025-09-0210:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-25-033536 |
| 2025-07-3117:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001739940-25-000028 |
| 2025-07-3110:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-028099 |
| 2025-07-2820:16 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001140361-25-027585 |
| 2025-06-0221:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-021143 |
| 2025-05-2010:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-25-019807 |
| 2025-05-0215:07 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001739940-25-000021 |
| 2025-05-0210:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-017006 |
| 2025-04-2820:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001140361-25-016027 |
| 2025-04-1820:20 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-014574 |
| 2025-03-1912:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-009365 |
| 2025-03-1420:35 ET | DEF 14A | Proxy statementPeriod 2025-04-23 | 0001739940-25-000015 |
| 2025-03-1311:42 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure | 0001140361-25-008555 |
| 2025-03-0321:15 ET | 8-K | 7.01 Regulation FD disclosure | 0001140361-25-006753 |
| 2025-02-2718:38 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001739940-25-000009 |
| 2025-01-3011:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-002386 |
| 2024-10-3117:36 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001739940-24-000033 |
| 2024-10-3110:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-044674 |
| 2024-09-0310:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-24-000274 |
| 2024-08-0114:34 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001739940-24-000028 |
| 2024-08-0110:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-24-000233 |
| 2024-06-2020:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950159-24-000218 |
| 2024-06-0610:15 ET | 8-K | 7.01 Regulation FD disclosure | 0000950159-24-000212 |
| 2024-05-0215:10 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001739940-24-000015 |
| 2024-05-0210:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950159-24-000134 |
| 2024-04-2620:30 ET | 8-K | 5.07 Shareholder vote results | 0000950159-24-000132 |
| 2024-04-2610:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events | 0000950159-24-000130 |
| 2024-03-1520:16 ET | DEF 14A | Proxy statementPeriod 2024-04-24 | 0001739940-24-000010 |
| 2024-03-0711:55 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950159-24-000103 |
| 2024-02-2919:48 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001739940-24-000005 |
| 2024-02-1511:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950159-24-000100 |
| 2024-02-1321:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-007429 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.